小鼠P311蛋白与类赖氨酰氧化酶-1相互作用的鉴定

P311是利用抑制差减杂交技术从小鼠肺组织中筛选到的一个肺泡发育上游调节基因.它高水平表达于肺泡发育的相关阶段,而在慢性阻塞性肺病(chronic obstructive pulmonary disease,COPD)患者肺组织中表达水平大大下降.为深入探讨P311蛋白的作用机制,构建pGBKT7-P311诱饵表达载体,利用酵母双杂交技术,从小鼠肺组织cDNA文库中筛选出P311相互作用蛋白类赖氨酰氧化酶-1(lysyl oxidase-like 1,Loxl-1).并通过体内外免疫共沉淀及双分子荧光互补实验进行验证.为进一步研究P311蛋白的生物学功能提供新的思路。     

抑制差减杂交克隆肺泡发育上游调节基因

肺泡是肺进行气体交换的基本功能单位,但对其发生、发育及调节机制的认识还十分有限。为克隆调节肺泡发生的新基因,我们利用抑制差减杂交技术,以与肺泡发生密切相关的原始肺泡期和肺泡期的小鼠肺为材料,分别相对于肺泡成熟期鼠肺组织构建了两个抑制差减杂交cDNA文库,从中筛选出118个肺泡发生的上游因子。这些基因涉及机体生长发育过程及其调节的多个方面。如可增加内皮细胞渗透性而参与肺血管系统的发生和重建的瞬时受体蛋白(TRPC4),通过刺激平滑肌生长促进肺泡壁毛细血管的发育凝集素(Lgalsl)等。特别是神经元蛋白3．1(亦称P311),因其同时特异表达于原始肺泡期和肺泡期而引起我们的注意。实时PCR进一步显示,P311表达于肺发育的全过程,但表达高峰仅出现于肺泡发育相关阶段,而在成熟肺组织中降至最低点。提示P311可能与肺泡形成密切相关。     

神经元蛋白3.1结合蛋白酵母双杂交筛选体系的建立

神经元蛋白3.1(P311)是肺泡发育的上游调节因子。以pEGFP-P311重组质粒为模板,利用PCR方法扩增P311基因编码序列。通过Nde I和BamH I位点插入诱饵载体pGBKT7,构建重组诱饵载体pGBKT7-P311。重组体转化酵母菌AH109进行自激活和毒性检测,结果 DNA-BD-P311融合蛋白无单独激活报告基因作用,对酵母菌亦无毒性。以出生11 d小鼠肺组织为材料,提取总RNA。逆转录产生单链cDNA,通过长距离PCR进行扩增。扩增产物ds cDNA电泳后可见大小为0.2～3.0 kb间的弥散状分布条带,说明文库cDNA可满足筛选要求。诱饵载体pGBKT7-P311的构建及相应小鼠肺组织cDNA文库的建立,为进一步利用酵母双杂交技术探讨P311功能奠定了基础。     

脑红蛋白在赛加羚羊主要内脏器官中的表达与定位

赛加羚羊(Saiga tatarica)属于我国一级重点保护野生动物,其原产地主要为高寒低氧地区,现存种群则主要栖息于中亚地区的荒漠及半荒漠草原上。脑红蛋白是一种存在于脊椎动物体内具有运输和储存血氧能力的球蛋白,在动物适应低氧过程中具有重要的生理功能。为了初步探究赛加羚羊对低氧环境的耐受性机制,运用免疫组织化学染色法与实时荧光定量PCR技术,对脑红蛋白及脑红蛋白基因(NGB)在赛加羚羊的心、肝、脾、肺、肾等5种主要内脏器官中的分布规律与表达情况进行了探究。免疫组织化学染色结果显示,脑红蛋白在赛加羚羊的心、肝、脾、肺、肾中均有分布,阳性表达主要分布在其心肌细胞、肝细胞、脾白髓区中的淋巴细胞、肺泡细胞以及肾小球内皮细胞。实时荧光定量PCR结果显示,脑红蛋白基因在赛加羚羊心、肝、脾、肺、肾中的表达量不同,脾的表达量最高,心的表达量次之,两者均显著高于肝、肺和肾(P < 0.05);其后依次为肝、肾、肺,其中,肝的表达量显著高于肾和肺(P < 0.05),肾和肺之间表达量差异不显著(P > 0.05),肺的表达量最低。上述研究表明,脑红蛋白在赛加羚羊的主要内脏器官中均有阳性表达,不同内脏器官中的表达量不同,这表明脑红蛋白可能参与了这些内脏器官的氧利用过程,具体机制有待进一步探讨。     

智力低下相关蛋白(FXR1P)与CMAS相互作用的生物学效应研究

脆性X综合征(FXS)是一种遗传性智力低下疾病,其发病率仅次于21三体综合征．脆性X智力低下蛋白(FMRP)是FXS的关键性致病因子,该蛋白由脆性X智力低下基因1(FMR1)编码所得．FMR1在神经肌肉和睾丸组织中广泛表达．脆性X相关蛋白1(FXR1P)则是由FMR1的同源基因脆性X相关基因1(FXR1)编码所得,并且与蛋白质和RNAs之间存在着相互作用．许多疾病都涉及到FXR1表达的改变．为了了解FXR1P与CMAS(胞嘧啶单核苷酸-N-乙酰神经氨酸合成酶)相互作用所产生的的生物学效应,我们构建了FXR1的过表达载体,并观察其在PC12细胞(大鼠鼠肾上腺嗜铬细胞瘤细胞)和VSMC(血管平滑肌细胞)中的表达以及继而对于细胞形态和CMAS活性相关的许多细胞指标的效应．我们证实,FXR1基因的过表达可以提高PC12细胞中CMAS的活性,并对于该类细胞的生长提供一定程度的保护作用．PC12细胞是一种较为常见的用于研究神经系统疾病的细胞系．结论：我们推测FXR1P是一个组织特异调节因子,可以改变PC12细胞而非VSMC细胞中神经节苷酯(GM1)的浓度．     

JSRV衣壳蛋白单克隆抗体的制备及免疫学鉴定

经纯化的JSRV-CA融合蛋白乳化后免疫Balb/c小鼠,四免后,取其脾细胞与SP2/0骨髓瘤细胞经杂交瘤技术进行融合．最终获得了三株稳定分泌单克隆抗体的细胞系．同时,分段克隆绵羊肺腺瘤病毒ca基因并构建原核表达质粒,在E． coli BL21中诱导表达．以获得的三株抗JSRV-CA蛋白的单克隆细胞分泌的McAb为一抗,应用Western blot对分段表达的CA蛋白进行肽探针扫描,初步鉴定了三株单抗识别的线性表位,并应用非竞争性ELISA法测定了三株单抗的功能性亲和常数．为建立特异性的病原诊断方法、分析CA蛋白的功能及疫苗设计奠定了基础．     

Ⅱ型肺泡细胞特异表达SARS冠状病毒核衣壳蛋白转基因小鼠的建立

目的:建立Ⅱ型肺泡细胞特异表达SARS冠状病毒(SARS-CoV)核衣壳蛋白(N蛋白)的转基因小鼠。方法:用分子克隆的方法构建包括肺表面活性蛋白A(SP-A)启动子、SARS-CoVN蛋白基因、β-半乳糖苷酶(LacZ)报告基因和人生长激素(hGH)polyA的转基因载体pSP-A-N。以显微注射的方法将8.3kb的转基因片段引入小鼠受精卵。通过PCR、Southern印迹和LacZ染色检测子代小鼠中转基因的整合及表达。结果:共注射952枚受精卵,移植至42只假孕母小鼠的输卵管中发育,获得子代小鼠128只,经PCR、Southern印迹鉴定,其中11只小鼠基因组上整合有SARS-CoVN蛋白基因,整合率为8.6%。鉴定结果显示,11只转基因首建者小鼠中有1只表达外源基因并能正常传代。LacZ染色结果表明N蛋白基因在转基因小鼠Ⅱ型肺上皮细胞中特异表达。结论:成功构建了Ⅱ型肺泡细胞特异表达SARS-CoVN蛋白的转基因小鼠,为深入研究该基因的病理生理学效应奠定了基础。     

甲型流感病毒重组血凝素蛋白的真核表达及免疫效力分析

利用真核表达系统稳定表达HA重组蛋白并评价其免疫原性及攻毒保护效果,为重组流感亚单位疫苗的研制提供更多的理论基础。本研究以H1N1型流感病毒HA胞外区域序列为目的基因构建重组质粒KS001-HA并转染至CHO细胞得到表达重组蛋白rHA的单克隆细胞株,通过离子交换层析法纯化rHA。将rHA与佐剂联合免疫小鼠以评估免疫原性,并对免疫后的小鼠进行攻毒,监测小鼠存活率和体重变化,检测其肺组织病毒载量,并分析肺组织的病理变化。重组质粒KS001-HA在CHO细胞中稳定整合并分泌表达rHA蛋白,其相对分子质量约70 kD,经PNGaseF酶处理后,蛋白大小变为60kD。纯化后rHA蛋白纯度>95%。加强免疫后小鼠血清抗体效价显著增强,佐剂配伍免疫效果优于rHA单独免疫,其中HA203佐剂配伍组15、30、60μg剂量组免疫效应显著高于阳性对照组H1N1疫苗原液组。攻毒后HA203佐剂配伍组无小鼠死亡,小鼠体重平均下降率低于10%,肺组织肺泡结构清晰,仅见肺泡壁轻度增厚,伴随少量的炎性细胞浸润,仅检测到少量呈灶性分布的棕黄色颗粒。本研究成功构建了重组质粒KS001-HA,于CHO细胞中表达,并...     

高质量抗体揭示Rad1蛋白在细胞中新的潜在活动机理

一组在进化上(从酵母到人)保守的基因Rad9、Rad1和Hus1在细胞周期监控点调控和DNA损伤修复中发挥重要作用．这三个蛋白可以形成环形异源三聚体,即9-1-1蛋白复合体．9-1-1复合体被认为是Rad9、Rad1和Hus1行使功能的主要形式．到目前为止,没有一个好的抗Rad1的抗体,严重阻碍了对Rad1和9-1-1复合体的研究．在本研究中,我们成功地制备了一株小鼠抗Rad1蛋白的单克隆抗体．这个抗体能够有效地检测小鼠和人的内源Rad1蛋白,可以用于酶联免疫吸附、蛋白质免疫印迹、免疫共沉淀和免疫荧光等实验．利用该抗体,我们发现在DNA损伤剂羟基脲(HU)的诱导下,小鼠Rad1蛋白在Rad9^+/+小鼠胚胎干细胞中表达明显增加,而在Rad9^-/-的小鼠胚胎干细胞中没有观察到该现象,这表明Rad9对Rad1的蛋白表达有调控作用．此外,内源的Rad1蛋白主要分布在细胞质中,在HU处理后并没有迁移进入细胞核的现象,这与先前广泛被人们所接受的在DNA损伤压力下Rad1和Hus1能够迁移进入细胞核并与Rad9形成9-1-1蛋白复合体的说法相矛盾．综合看来,Rad1和9-1-1蛋白复合体的分子作用机制比预期的要复杂,我们成功制备的Rad1单克隆抗体将成为研究Rad1以及9-1-1蛋白复合体的强有力的工具．     

烟曲霉硫氧还蛋白还原酶对侵袭性曲霉病小鼠的免疫保护作用

目的探讨烟曲霉硫氧还蛋白还原酶(thioredoxin reductase,TR)对侵袭性曲霉病(invasive aspergillosis,IA)的免疫保护作用。方法 C57BL/6小鼠随机分为免疫组和对照组,免疫组小鼠用重组TR免疫2次。感染烟曲霉前用环磷酰胺和地塞米松对全部小鼠进行免疫抑制处理,通过气道穿刺法向气管内注入烟曲霉孢子悬液,建立IA疾病模型。观察两组小鼠的存活率、局部器官真菌载量、肺组织病理变化、肺泡灌洗液细胞分类计数,评估TR蛋白的免疫保护作用。结果存活率:免疫组小鼠7d存活率为64.7%,对照组为0。肺组织匀浆烟曲霉CFU中位数:存活小鼠为0,死亡小鼠为44(P25,P75为21,70)(P0.01)。组织病理学检观察:死亡小鼠肺肿胀出血、肺泡间隔增宽、大量炎症细胞聚集、组织灶状坏死,并有大量烟曲霉菌丝存在,而存活小鼠肺组织损伤程度轻,且组织间无菌丝。肺泡灌洗液涂片染色细胞计数显示:存活小鼠单个核细胞约占84.2%,中性粒细胞仅占15.8%;死亡小鼠单个核细胞占33.6%,中性粒细胞约占66.4%。结论烟曲霉重组蛋白TR能诱导小鼠产生抵抗IA的免疫保护力,是一个有潜力的保护性抗原。     

Localization of pulmonary surfactant protein during mouse lung development

During lung development type II alveolar epithelial cells produce extracellular pulmonary surfactant. Polyclonal antibodies were produced against nonserum proteins associated with human surfactant. The present studies were designed (i) to determine if mouse surfactant proteins were antigenically cross-reactive with polyclonal antibodies directed against human surfactant proteins; and (ii) to determine surfactant protein localization during fetal, neonatal, and adult mouse lung development. Two-dimensional gel electrophoresis studies in conjunction with immunologic techniques provided evidence that mouse and human surfactant proteins shared antigenic determinants. The major monomeric form of mouse surfactant protein in a glycoprotein of approximately Mr 35,000 under reducing conditions. A less abundant form was identified as a Mr 45,000 polypeptide. Immunohistochemical localization showed that type II cells contain surfactant protein at Theiler stage 26. A gradient of immunostaining was localized within alveolar surfaces. The antigen was not detected in heart, blood vessels, or pulmonary interstitial cells. Surfactant protein was detected lining alveolar surfaces in mature adult lung. The distribution of this protein during fetal and neonatal lung morphogenesis suggests that this extracellular constituent of pulmonary surfactant may be extremely useful as a phenotypic marker with which to evaluate normal and abnormal lung development.     

Angiogenesis and morphogenesis of murine fetal distal lung in an allograft model

Neovascularization is crucial to lung morphogenesis; however, factors determining vessel growth and formation are poorly understood. The goal of our study was to develop an allograft model that would include maturation of the distal lung, thereby ultimately allowing us to study alveolar development, including microvascular formation. We transplanted 14-day gestational age embryonic mouse lung primordia subcutaneously into the back of nude mice for 3.5-14 days. Lung morphogenesis and neovascularization were evaluated by light microscopy, in situ hybridization, and immunohistochemical techniques. Embryonic 14-day gestational age control lungs had immature structural features consistent with pseudoglandular stage of lung development. In contrast, 14 days after subcutaneous transplantation of a 14-day gestational age lung, the allograft underwent significant structural morphogenesis and neovascularization. This was demonstrated by continued neovascularization and cellular differentiation, resulting in mature alveoli similar to those noted in the 2-day postnatal neonatal lung. Confirmation of maturation of the allograft was provided by progressive type II epithelial cell differentiation as evidenced by enhanced local expression of mRNA for surfactant protein C and a threefold (P < 0.008) increase in vessel formation as determined by immunocytochemical detection of platelet endothelial cell adhesion molecule-1 expression. Using the tyrosine kinase Flk-1 receptor (flk-1) LacZ transgene embryos, we determined that the neovascularization within the allograft was from the committed embryonic lung endothelium. Therefore, we have developed a defined murine allograft model that can be used to study distal lung development, including neovascularization. The model may be useful when used in conjunction with an altered genetic background (knockout or knock in) of the allograft and has the further decided advantage of bypassing placental barriers for introduction of pharmacological agents or DNA directly into the lung itself.     

JNK suppresses pulmonary fibroblast elastogenesis during alveolar development

Background

The formation of discrete elastin bands at the tips of secondary alveolar septa is important for normal alveolar development, but the mechanisms regulating the lung elastogenic program are incompletely understood. JNK suppress elastin synthesis in the aorta and is important in a host of developmental processes. We sought to determine whether JNK suppresses pulmonary fibroblast elastogenesis during lung development.

Methods

Alveolar size, elastin content, and mRNA of elastin-associated genes were quantitated in wild type and JNK-deficient mouse lungs, and expression profiles were validated in primary lung fibroblasts. Tropoelastin protein was quantitated by Western blot. Changes in lung JNK activity throughout development were quantitated, and pJNK was localized by confocal imaging and lineage tracing.

Results

By morphometry, alveolar diameters were increased by 7% and lung elastin content increased 2-fold in JNK-deficient mouse lungs compared to wild type. By Western blot, tropoelastin protein was increased 5-fold in JNK-deficient lungs. Postnatal day 14 (PND14) lung JNK activity was 11-fold higher and pJNK:JNK ratio 6-fold higher compared to PN 8 week lung. Lung tropoelastin, emilin-1, fibrillin-1, fibulin-5, and lysyl oxidase mRNAs inversely correlated with lung JNK activity during alveolar development. Phosphorylated JNK localized to pulmonary lipofibroblasts. PND14 JNK-deficient mouse lungs contained 7-fold more tropoelastin, 2,000-fold more emilin-1, 800-fold more fibrillin-1, and 60-fold more fibulin-5 than PND14 wild type lungs. Primarily lung fibroblasts from wild type and JNK-deficient mice showed similar differences in elastogenic mRNAs.

Conclusions

JNK suppresses fibroblast elastogenesis during the alveolar stage of lung development.     

Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis

Many membrane-bound protein precursors, including cytokines and growth factors, are proteolytically shed to yield soluble intercellular regulatory ligands. The responsible protease, tumor necrosis factor-alpha converting enzyme (TACE/ADAM-17), is a transmembrane metalloprotease-disintegrin that cleaves multiple cell surface proteins, although it was initially identified for the enzymatic release of tumor necrosis factor-alpha (TNF-alpha). Mammalian lung growth and development are tightly controlled by cytokines and peptide growth factors. However, the biological function of the cell shedding mechanism during lung organogenesis is not understood. We therefore evaluated the role of TACE as a "sheddase" during lung morphogenesis by analyzing the developmental phenotypes of lungs in mice with an inactive TACE gene in both in vivo and ex vivo organ explant culture. Neonatal TACE-deficient mice had visible respiratory distress and their lungs failed to form normal saccular structures. These newborn mutant lungs had fewer peripheral epithelial sacs with deficient septation and thick-walled mesenchyme, resulting in reduced surface for gas exchange. At the canalicular stage of E16.5, the lungs of TACE mutant mice were impaired in branching morphogenesis, inhibited in epithelial cell proliferation and differentiation, and delayed in vasculogenesis. Embryonic TACE knockout mouse lungs (E12) branched poorly compared to wild-type lungs, when placed into serumless organ culture. Gene expression of both surfactant protein-C and aquaporin-5 were inhibited in cultured TACE-mutant embryonic lungs, indicating defects in both branching and peripheral epithelial cytodifferentiation in the absence of TACE protein. Furthermore, both the hypoplastic phenotype and the delayed cytodifferentiation in TACE-deficient lungs were rescued by exogenous addition of soluble stimulatory factors including either TNF-alpha or epidermal growth factor in embryonic lung culture. Thus, the impaired lung branching and maturation without TACE suggest a broad role for TACE in the processing of multiple membrane-anchored proteins, one or more of which is essential for normal lung morphogenesis. Taken together, our data indicate that the TACE-mediated proteolytic mechanism which enzymatically releases membrane-tethered proteins plays an indispensable role in lung morphogenesis, and its inactivation leads to abnormal lung development.